시장보고서
상품코드
1278981

백금 항암제 시장 : 세계 산업 분석, 동향, 시장 규모, 예측(-2030년)

Platinum Based Cancer Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

발행일: | 리서치사: Infinium Global Research (IGR) | 페이지 정보: 영문 255 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 백금 항암제 시장 규모는 2023년부터 2030년까지 예측 기간 동안 3% 이상의 CAGR로 성장할 것으로 예상됩니다.

세계 백금 항암제 시장을 조사했으며, 시장 개요, 시장 영향요인 분석, 시장 규모 추이 및 예측, 각종 부문별·지역별 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

제2장 주요 요약

제3장 세계의 백금 항암제 시장 개요

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • Porter's Five Forces 분석
  • IGR-성장 매트릭스 분석
  • 밸류체인 분석
  • TAM SAM SOM 분석

제4장 백금 항암제 시장 거시적 지표 분석

제5장 세계의 백금 항암제 시장 : 유형별

  • 시스플라틴
  • 옥살리플라틴
  • 카르보플라틴
  • 기타

제6장 세계의 백금 항암제 시장 : 용도별

  • 대장암
  • 난소암
  • 폐암
  • 기타

제7장 세계의 백금 항암제 시장 : 유통 채널별

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 백금 항암제 시장 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제9장 기업 개요·경쟁 상황

  • 경쟁 환경
  • 기업 개요
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • Eli Lilly and Company
    • Accord Healthcare
    • Guizhou Yibai Pharmaceutical Co., Ltd.
    • Bayer AG
    • Qilu Pharmaceutical Co., Ltd.
    • Dr. Reddy's Laboratories Ltd.
KSM 23.06.02

The report on the global platinum based cancer drug market provides qualitative and quantitative analysis for the period from 2021-2030. The report predicts the global platinum based cancer drug market to grow with a CAGR of Over 3% over the forecast period from 2023-2030. The study on platinum based cancer drug market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The report on platinum based cancer drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global platinum based cancer drug market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global platinum based cancer drug market over the period of 2021-2030. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Increasing prevalence of cancer.
  • Increased demand for cancer drug due to rise in colorectal, prostate, cervical, and breast cancer patients.

2) Restraints

  • Side effects of drugs.
  • Stringent government rules and regulations.

3) Opportunities

  • Investment of various companies in research and development in the emerging market.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global platinum based cancer drug market is segmented on the basis of type, application, and distribution channel.

The Global Platinum Based Cancer Drug Market by Type

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others

The Global Platinum Based Cancer Drug Market by Application

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others

The Global Platinum Based Cancer Drug Market by Distribution Channel

  • Hospital-based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Company Profiles

The companies covered in the report include:

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sanofi
  • Eli Lilly and Company
  • Accord Healthcare
  • Guizhou Yibai Pharmaceutical Co., Ltd.
  • Bayer AG
  • Qilu Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.

What does this Report Deliver?

  • 1. Comprehensive analysis of the global as well as regional markets of the platinum based cancer drug market.
  • 2. Complete coverage of all the segments in the platinum based cancer drug market to analyze the trends, developments in the global market and forecast of market size up to 2030.
  • 3. Comprehensive analysis of the companies operating in the global platinum based cancer drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  • 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

Chapter 2. Executive Summary

  • 2.1. Platinum Based Cancer Drug Market Highlights
  • 2.2. Platinum Based Cancer Drug Market Projection
  • 2.3. Platinum Based Cancer Drug Market Regional Highlights

Chapter 3. Global Platinum Based Cancer Drug Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Porter`s Five Forces Analysis
  • 3.4. IGR-Growth Matrix Analysis
    • 3.4.1. IGR-Growth Matrix Analysis by Type
    • 3.4.2. IGR-Growth Matrix Analysis by Application
    • 3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
    • 3.4.4. IGR-Growth Matrix Analysis by Region
  • 3.5. Value Chain Analysis of Platinum Based Cancer Drug Market
  • 3.6. TAM SAM SOM Analysis for Platinum Based Cancer Drug Market
    • 3.6.1. TAM SAM SOM Forecast Analysis (USD Million) 2023

Chapter 4. Platinum Based Cancer Drug Market Macro Indicator Analysis

Chapter 5. Global Platinum Based Cancer Drug Market by Type

  • 5.1. Cisplatin
  • 5.2. Oxaliplatin
  • 5.3. Carboplatin
  • 5.4. Others

Chapter 6. Global Platinum Based Cancer Drug Market by Application

  • 6.1. Colorectal Cancer
  • 6.2. Ovarian Cancer
  • 6.3. Lung Cancer
  • 6.4. Others

Chapter 7. Global Platinum Based Cancer Drug Market by Distribution Channel

  • 7.1. Hospital-based Pharmacies
  • 7.2. Retail Pharmacies
  • 7.3. Online Pharmacies

Chapter 8. Global Platinum Based Cancer Drug Market by Region 2023-2030

  • 8.1. North America
    • 8.1.1. North America Platinum Based Cancer Drug Market by Type
    • 8.1.2. North America Platinum Based Cancer Drug Market by Application
    • 8.1.3. North America Platinum Based Cancer Drug Market by Distribution Channel
    • 8.1.4. North America Platinum Based Cancer Drug Market by Country
      • 8.1.4.1. The U.S. Platinum Based Cancer Drug Market
        • 8.1.4.1.1. The U.S. Platinum Based Cancer Drug Market by Type
        • 8.1.4.1.2. The U.S. Platinum Based Cancer Drug Market by Application
        • 8.1.4.1.3. The U.S. Platinum Based Cancer Drug Market by Distribution Channel
      • 8.1.4.2. Canada Platinum Based Cancer Drug Market
        • 8.1.4.2.1. Canada Platinum Based Cancer Drug Market by Type
        • 8.1.4.2.2. Canada Platinum Based Cancer Drug Market by Application
        • 8.1.4.2.3. Canada Platinum Based Cancer Drug Market by Distribution Channel
      • 8.1.4.3. Mexico Platinum Based Cancer Drug Market
        • 8.1.4.3.1. Mexico Platinum Based Cancer Drug Market by Type
        • 8.1.4.3.2. Mexico Platinum Based Cancer Drug Market by Application
        • 8.1.4.3.3. Mexico Platinum Based Cancer Drug Market by Distribution Channel
  • 8.2. Europe
    • 8.2.1. Europe Platinum Based Cancer Drug Market by Type
    • 8.2.2. Europe Platinum Based Cancer Drug Market by Application
    • 8.2.3. Europe Platinum Based Cancer Drug Market by Distribution Channel
    • 8.2.4. Europe Platinum Based Cancer Drug Market by Country
      • 8.2.4.1. Germany Platinum Based Cancer Drug Market
        • 8.2.4.1.1. Germany Platinum Based Cancer Drug Market by Type
        • 8.2.4.1.2. Germany Platinum Based Cancer Drug Market by Application
        • 8.2.4.1.3. Germany Platinum Based Cancer Drug Market by Distribution Channel
      • 8.2.4.2. United Kingdom Platinum Based Cancer Drug Market
        • 8.2.4.2.1. United Kingdom Platinum Based Cancer Drug Market by Type
        • 8.2.4.2.2. United Kingdom Platinum Based Cancer Drug Market by Application
        • 8.2.4.2.3. United Kingdom Platinum Based Cancer Drug Market by Distribution Channel
      • 8.2.4.3. France Platinum Based Cancer Drug Market
        • 8.2.4.3.1. France Platinum Based Cancer Drug Market by Type
        • 8.2.4.3.2. France Platinum Based Cancer Drug Market by Application
        • 8.2.4.3.3. France Platinum Based Cancer Drug Market by Distribution Channel
      • 8.2.4.4. Italy Platinum Based Cancer Drug Market
        • 8.2.4.4.1. Italy Platinum Based Cancer Drug Market by Type
        • 8.2.4.4.2. Italy Platinum Based Cancer Drug Market by Application
        • 8.2.4.4.3. Italy Platinum Based Cancer Drug Market by Distribution Channel
      • 8.2.4.5. Spain Platinum Based Cancer Drug Market
        • 8.2.4.5.1. Spain Platinum Based Cancer Drug Market by Type
        • 8.2.4.5.2. Spain Platinum Based Cancer Drug Market by Application
        • 8.2.4.5.3. Spain Platinum Based Cancer Drug Market by Distribution Channel
      • 8.2.4.6. Rest of Europe Platinum Based Cancer Drug Market
        • 8.2.4.6.1. Rest of Europe Platinum Based Cancer Drug Market by Type
        • 8.2.4.6.2. Rest of Europe Platinum Based Cancer Drug Market by Application
        • 8.2.4.6.3. Rest of Europe Platinum Based Cancer Drug Market by Distribution Channel
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific Platinum Based Cancer Drug Market by Type
    • 8.3.2. Asia Pacific Platinum Based Cancer Drug Market by Application
    • 8.3.3. Asia Pacific Platinum Based Cancer Drug Market by Distribution Channel
    • 8.3.4. Asia Pacific Platinum Based Cancer Drug Market by Country
      • 8.3.4.1. China Platinum Based Cancer Drug Market
        • 8.3.4.1.1. China Platinum Based Cancer Drug Market by Type
        • 8.3.4.1.2. China Platinum Based Cancer Drug Market by Application
        • 8.3.4.1.3. China Platinum Based Cancer Drug Market by Distribution Channel
      • 8.3.4.2. Japan Platinum Based Cancer Drug Market
        • 8.3.4.2.1. Japan Platinum Based Cancer Drug Market by Type
        • 8.3.4.2.2. Japan Platinum Based Cancer Drug Market by Application
        • 8.3.4.2.3. Japan Platinum Based Cancer Drug Market by Distribution Channel
      • 8.3.4.3. India Platinum Based Cancer Drug Market
        • 8.3.4.3.1. India Platinum Based Cancer Drug Market by Type
        • 8.3.4.3.2. India Platinum Based Cancer Drug Market by Application
        • 8.3.4.3.3. India Platinum Based Cancer Drug Market by Distribution Channel
      • 8.3.4.4. South Korea Platinum Based Cancer Drug Market
        • 8.3.4.4.1. South Korea Platinum Based Cancer Drug Market by Type
        • 8.3.4.4.2. South Korea Platinum Based Cancer Drug Market by Application
        • 8.3.4.4.3. South Korea Platinum Based Cancer Drug Market by Distribution Channel
      • 8.3.4.5. Australia Platinum Based Cancer Drug Market
        • 8.3.4.5.1. Australia Platinum Based Cancer Drug Market by Type
        • 8.3.4.5.2. Australia Platinum Based Cancer Drug Market by Application
        • 8.3.4.5.3. Australia Platinum Based Cancer Drug Market by Distribution Channel
      • 8.3.4.6. Rest of Asia-Pacific Platinum Based Cancer Drug Market
        • 8.3.4.6.1. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Type
        • 8.3.4.6.2. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Application
        • 8.3.4.6.3. Rest of Asia-Pacific Platinum Based Cancer Drug Market by Distribution Channel
  • 8.4. RoW
    • 8.4.1. RoW Platinum Based Cancer Drug Market by Type
    • 8.4.2. RoW Platinum Based Cancer Drug Market by Application
    • 8.4.3. RoW Platinum Based Cancer Drug Market by Distribution Channel
    • 8.4.4. RoW Platinum Based Cancer Drug Market by Sub-region
      • 8.4.4.1. Latin America Platinum Based Cancer Drug Market
        • 8.4.4.1.1. Latin America Platinum Based Cancer Drug Market by Type
        • 8.4.4.1.2. Latin America Platinum Based Cancer Drug Market by Application
        • 8.4.4.1.3. Latin America Platinum Based Cancer Drug Market by Distribution Channel
      • 8.4.4.2. Middle East Platinum Based Cancer Drug Market
        • 8.4.4.2.1. Middle East Platinum Based Cancer Drug Market by Type
        • 8.4.4.2.2. Middle East Platinum Based Cancer Drug Market by Application
        • 8.4.4.2.3. Middle East Platinum Based Cancer Drug Market by Distribution Channel
      • 8.4.4.3. Africa Platinum Based Cancer Drug Market
        • 8.4.4.3.1. Africa Platinum Based Cancer Drug Market by Type
        • 8.4.4.3.2. Africa Platinum Based Cancer Drug Market by Application
        • 8.4.4.3.3. Africa Platinum Based Cancer Drug Market by Distribution Channel

Chapter 9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Platinum Based Cancer Drug Market
  • 9.2. Companies Profiles
    • 9.2.1. Novartis AG
    • 9.2.2. Teva Pharmaceutical Industries Ltd.
    • 9.2.3. Pfizer Inc.
    • 9.2.4. Sanofi
    • 9.2.5. Eli Lilly and Company
    • 9.2.6. Accord Healthcare
    • 9.2.7. Guizhou Yibai Pharmaceutical Co., Ltd.
    • 9.2.8. Bayer AG
    • 9.2.9. Qilu Pharmaceutical Co., Ltd.
    • 9.2.10. Dr. Reddy's Laboratories Ltd.
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제